Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07680517 · ClinicalTrials.gov registry record · NA
Examining the Efficacy of Short-Term Intensive PTSD Treatment on Psychological and Cognitive Impairment Symptoms
A NA study, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT07680517 is a NA study that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 120 participants.
The verdict
NCT07680517, a NA study, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
Our long-term goal is to provide rapid and sustained reductions of trauma and cognitive-related symptoms among Special Operations personnel with PTSD or subthreshold PTSD. The primary objective of this project is to examine the effectiveness of massed PTSD treatment (i.e., CPT and EMDR) in "real-world" military settings. CPT and EMDR are both empirically supported psychotherapies for PTSD. To accomplish this objective, we will enroll military personnel meeting diagnostic criteria for PTSD or subthreshold PTSD (i.e., meeting threshold levels for 3 of 4 symptom criteria).
Interventions
- BEHAVIORAL Cognitive Processing Therapy
- BEHAVIORAL Eye-Movement Desensitization and Reprocessing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2028-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07680517
The ClinicalTrials.gov registry entry for NCT07680517 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Processing Therapy is the first listed.
NCT07680517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07680517 about?
NCT07680517 is a clinical study titled "Examining the Efficacy of Short-Term Intensive PTSD Treatment on Psychological and Cognitive Impairment Symptoms". Our long-term goal is to provide rapid and sustained reductions of trauma and cognitive-related symptoms among Special Operations personnel with PTSD or subthreshold PTSD. The primary objective of this project is to examine the effectiveness of massed PTSD treatment (i.e., CPT and EMDR) in "real-wor...
What is the current status of trial NCT07680517?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-04-01. Estimated completion is 2028-08.
What interventions are being tested in trial NCT07680517?
The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL), Eye-Movement Desensitization and Reprocessing (BEHAVIORAL).
Who is sponsoring clinical trial NCT07680517?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.